Endoscopic ultrasound-guided transmural drainage for ... Endoscopic ultrasound-guided transmural...

download Endoscopic ultrasound-guided transmural drainage for ... Endoscopic ultrasound-guided transmural drainage

of 26

  • date post

  • Category


  • view

  • download


Embed Size (px)

Transcript of Endoscopic ultrasound-guided transmural drainage for ... Endoscopic ultrasound-guided transmural...

  • Instructions for use

    Title Endoscopic ultrasound-guided transmural drainage for pancreatic fistula or pancreatic duct dilation after pancreaticsurgery

    Author(s) Onodera, Manabu; Kawakami, Hiroshi; Kuwatani, Masaki; Kudo, Taiki; Haba, Shin; Abe, Yoko; Kawahata, Shuhei;Eto, Kazunori; Nasu, Yuya; Tanaka, Eiichi; Hirano, Satoshi; Asaka, Masahiro

    Citation Surgical Endoscopy, 26(6), 1710-1717https://doi.org/10.1007/s00464-011-2097-z

    Issue Date 2012-06

    Doc URL http://hdl.handle.net/2115/52926

    Rights The original publication is available at www.springerlink.com

    Type article (author version)

    File Information SE26-6_1710-1717.pdf

    Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP


  • Endoscopic ultrasound-guided transmural drainage for pancreatic fistula or pancreatic

    duct dilatation after pancreatic surgery

    Manabu Onodera 1)

    , Hiroshi Kawakami 1)

    , Masaki Kuwatani 1)

    , Taiki Kudo 1)

    , Shin Haba 1)


    Yoko Abe 1)

    , Shuhei Kawahata 1)

    , Kazunori Eto 1)

    , Yuya Nasu 2)

    , Eiichi Tanaka 2)

    , Satoshi

    Hirano 2)

    , and Masahiro Asaka 1)

    1) Department of Gastroenterology, Hokkaido University Graduate School of Medicine

    2) Department of Surgical Oncology, Hokkaido University Graduate School of Medicine

    Author contributions: Onodera M and Kawakami H contributed equally to this work

    Address correspondence to: Hiroshi Kawakami, MD, PhD.

    Department of Gastroenterology, Hokkaido University Graduate School of Medicine, Sapporo,

    060-8638, Japan

    Tel: +81-11-716-1161

    Fax: +81-11-706-7867 (ext.5918)

    E-mail: hiropon@med.hokudai.ac.jp

    Running title: EUS-TD of pancreatic fistula

    Key words: EUS-guided drainage, EUS-guided transmural drainage, pancreatic fistula, stasis

    of pancreatic juice, pancreatic surgery

  • Abstract

    Background Endoscopic ultrasound (EUS)-guided drainage is widely used to manage

    pancreatic pseudocysts. Several studies have reported the use of EUS-guided drainage for

    pancreatic fistula and stasis of pancreatic juice caused by stricture of the pancreatic duct after

    pancreatic resection.

    Methods In total, 262 patients underwent surgery involving pancreatic resection in our hospital

    from April 2005 to March 2010. Ninety patients (34%) developed a grade B or C postoperative

    pancreatic fistula (POPF) that required additional treatment. We performed EUS-guided

    transmural drainage (EUS-TD) for six patients (2.1%) with a pancreatic fistula or dilatation of

    the main pancreatic duct visible by EUS. Eighteen patients (6.8%) received percutaneous

    drainage. The success rates of EUS-TD and percutaneous drainage were compared in a

    retrospective analysis.

    Results EUS-TD was successfully performed without complications in all six cases, with five

    of the six patients being successfully treated with only one trial of EUS-TD. The final technical

    success rate was 100% for EUS-TD and for percutaneous drainage. Both the short-term and

    long-term clinical success rates of EUS-TD were 100%, and those of percutaneous drainage

    were 61.1% and 83%, respectively. The differences in these rates were not significant

    (short-term success, P = 0.091; long-term success, P = 0.403). However, the period to clinical

    success was significantly shorter with EUS-TD (5.8 days) than with percutaneous drainage

    (30.4 days; P = 0.0013) in our series.

    Conclusions EUS-TD appears to be a safe and technically feasible alternative to percutaneous

    drainage and may be considered a first-line therapy for pancreatic fistulas visible by EUS.

  • Abbreviations:

    CT, computed tomography; EUS, endoscopic ultrasound; EUS-TD, EUS-guided transmural

    drainage; MPD, main pancreatic duct; POPF, postoperative pancreatic fistula; US, ultrasound;

    DPDS, Disconnected pancreatic duct syndrome

  • Introduction

    Postoperative pancreatic fistula (POPF), a serious and potentially lethal complication, is the

    main unsolved problem in pancreatic surgery. The principle underlying this treatment is

    drainage of the pancreatic fluid that has collected within the abdominal cavity. The surgeon

    usually places the drainage tube near the pancreatic stump or the anastomotic site of

    pancreatoenterostomy to drain the collected fluid in cases of leakage (pancreatic fistula).

    However, additional drainage may be needed when the drainage work during the operation is

    inadequate. Despite the expansive growth pattern of pancreatic pseudocysts followed by acute

    or chronic pancreatitis, the POPF space extends to the peritoneal cavity between visceral

    organs. This space is usually located deep in the peritoneal cavity and it has an irregular and

    complex shape. These caused treatment with both surgical and interventional ultrasound (US)

    or computed tomography (CT)-guided drainage procedures to be problematic. The incidence

    of postoperative pancreatic fistula (POPF) has been reported to be 5–20% after

    pancreaticoduodenectomy and is associated with high mortality [1]. The Japanese Society of

    Hepato-Biliary-Pancreatic Surgery reported that the rate of POPF after

    pancreaticoduodenectomy was 30.2% [1]. Even with recent advances in pancreatic surgery,

    POPF remains the major contributor to morbidity after pancreatic resection.

    The treatment of choice for POPF is external or internal drainage of pancreatic juice, which

    can be accomplished by surgical drainage, image-guided percutaneous drainage, or endoscopic

    drainage. A surgical cyst-enteric anastomosis has traditionally been performed, with high

    morbidity rates ranging from 7 to 37% [2, 3]. Percutaneous drainage offers satisfying results,

    but it requires a long therapy period (several weeks to months) owing to the indwelling catheter

    and is occasionally associated with the formation of an external fistula [4, 5]. Furthermore,

  • cutaneopancreatic fistulas that form after percutaneous drainage are usually intractable.

    Endoscopic drainage has been performed increasingly during the last 10 years [6–8].

    Two approaches have been used for endoscopic access: through the gastrointestinal wall by

    creating a cystogastrostomy/cystoduodenostomy (transmural drainage) or via the papilla

    (transpapillary drainage). Both approaches, which usually require the insertion of one or more

    plastic stents [9], have success rates of 70–87% and complication rates of 11–34% [10, 11].

    Recently, endoscopic ultrasound (EUS)-guided transmural drainage (EUS-TD) has

    been widely used to manage pancreatic pseudocysts, and its applications have been extended

    gradually with the development of more innovative techniques and devices. Several reports

    have indicated the feasibility of EUS-guided drainage of pancreatic fistulae and stasis of

    pancreatic juice caused by a pancreatic duct stricture after pancreatic resection [12, 13].

    However, no detailed reports are available comparing EUS-TD and percutaneous drainage of a

    pancreatic fistula after pancreatic resection. To examine the utility and efficacy of EUS-TD, we

    report six consecutive successful pancreatic fistula and pancreatic duct dilatation cases treated

    by EUS-TD through the gastrointestinal tract and compare the outcomes with those of cases

    treated by conventional percutaneous drainage.

    Patients and methods

    In total, 262 patients underwent surgery involving pancreatic resection at our hospital from

    April, 2005 to March, 2010. A total of 172 patients (65%) did not have POPF and did not

    undergo additional treatment. Ninety patients (34%) developed POPF and required additional

    interventional treatment because they had symptoms such as fever and abdominal pain.

    Sixty-six patients have been cured by conservative therapies, while 24 have not since a convex

  • array echo endoscope was introduced to our institute in April 2006. When POPFs were visible

    by EUS, EUS-TD was the first choice for their treatment. Percutaneous drainage was the

    second choice for treatment of refractory POPFs with symptoms or if they were not visible by

    EUS. As a result, POPFs in five patients (2.1%) and dilatation of the main pancreatic duct

    (MPD) caused by a stricture of the anastomosis in one, were detected by EUS and treated by

    EUS-TD, and patients with a POPF not visible by EUS were treated with percutaneous

    drainage (18 cases, 6.8%) or with a surgical drain followed by primary surgery (66 cases, 25%)

    for the duration above.

    In the six patients treated with EUS-TD (Table 1), initial surgical indications were

    pancreatic carcinoma in three, bile duct carcinoma in two, and ampullary carcinoma in one.

    Pancreatoduodenectomy had been performed in three cases; hepatopancreatoduodenectomy, in

    two; and distal pancreatectomy, in one. After surgery, five patients (cases 1–5) developed a

    POPF, and one (case 6) developed dilatation of the MPD. Three patients (cases 1, 2, and 6)

    experienced fever, abdominal pain, or general